Insider trades

Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.

Open-market buys
518 trades
$10.3T in total
Open-market sales
1,246 trades
$1.4B in total
Insiders filing
582 insiders
Last 7 days
Trade type
Director
LipocineLPCN
Open-market buy09/29–09/3010/0125,007 sh2 trades$2.20avg.$55,042.65+11.6%
LipocineLPCN
Open-market buy09/2809/3012,561 sh$2.16$27,131.76+6.2%
LipocineLPCN
Open-market buy04/0704/0740,000 sh$2.03$81,200+24.4%
LipocineLPCN
Open-market buy04/0604/0625,000 sh$2.03$50,750+18.4%
LipocineLPCN
Open-market buy04/0604/06123,000 sh$2.05$252,150+301.5%
LipocineLPCN
Open-market buy04/0204/0225,000 sh$2.02$50,500+22.6%
Mahesh V. PatelCEO and President
LipocineLPCN
Open-market buy23/05/2523/05/258,706 sh$5.03$43,791.18+8.8%
Mahesh V. PatelCEO and President
LipocineLPCN
Open-market buy23/03/2423/03/24150,000 sh$0.32$48,000+9.8%
LipocineLPCN
Open-market buy23/03/2023/03/204,000 sh$0.34$1,360+39.5%
Mahesh V. PatelCEO and President
LipocineLPCN
Open-market buy23/03/1723/03/1750,000 sh$0.33$16,500+3.4%